A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsored by Eli Lilly and Company
About this study
The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.
Where this study is enrolling (32)
- I'm interested
Medical Dermatology Specialists
Phoenix, Arizona
- Call 818-350-7482
Northridge Clinical Trials
Northridge, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 510-797-0140
Center For Dermatology Clinical Research, Inc.
Fremont, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 714-531-2966
First OC Dermatology Research Inc
Fountain Valley, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 424-393-0005
Metropolis Dermatology
Los Angeles, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 32 locations
- Call 954-400-1725
Encore Medical Research
Hollywood, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 954-674-3535
Skin Care Research
Hollywood, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 305-456-9062
NeoClinical Research
Hialeah, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 813-948-7550
MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research
Tampa, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 678-702-3376
Southeast Research Specialists
Douglasville, Georgia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 317-516-5030
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 317-837-6082
The Indiana Clinical Trials Center, PC
Plainfield, Indiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 270-213-7777
Equity Medical - Bowling Green
Bowling Green, Kentucky
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 616-326-0114
The Derm Institute of West Michigan
Caledonia, Michigan
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 734-222-9630
David Fivenson, MD, PLC
Ann Arbor, Michigan
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 775-336-3658
Skin Cancer and Dermatology Institute - Reno
Reno, Nevada
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 617-833-9995
Stracskin
Portsmouth, New Hampshire
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 551-278-8680
Care Access - Hoboken
Hoboken, New Jersey
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 212-466-6550
Equity Medical
New York, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 800-785-3150
Onsite Clinical Solutions - Huntersville
Huntersville, North Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 330-422-3234
Optima Research - Boardman
Boardman, Ohio
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 503-226-3376
Oregon Dermatology and Research Center
Portland, Oregon
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 803-731-9600
Columbia Dermatology & Aesthetics
Columbia, South Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 629-895-1775
DelRicht Research - Thompson's Station
Smyrna, Tennessee
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 512-279-2545
Austin Institute for Clinical Research
Pflugerville, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 713-661-4383
Bellaire Dermatology Associates
Bellaire, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 214-361-2008
Modern Research Associates, PLLC
Dallas, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Center for Clinical Studies
Houston, Texas
- Call 210-852-2779
Texas Dermatology and Laser Specialists
San Antonio, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 281-333-2288
Center for Clinical Studies
Webster, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 206-248-5020
Dermatology of Seattle
Burien, Washington
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 425-455-2275
Bellevue Dermatology Clinic
Bellevue, Washington
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓Have a diagnosis of moderate-to-severe plaque PsO, as defined by a dermatologist or other experienced clinician treated PsO (for example, allergologist, nurse practitioner or physician assistant)
- ✓Have body mass index (BMI) of 30 kilograms per meter squared (kg/m²) or greater (obesity) or 27 kg/m² to \<30 kg/m² (overweight) in the presence of at least 1 weight-related comorbid condition (hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular diseases).
- ✓Must have initiated treatment with ixekizumab for approximately 3 months (± 1 month) prior to decision to add tirzepatide.
- ✓Must be able to initiate tirzepatide (Day 0) within 30 days of treatment decision (baseline/screening).
Exclusion criteria
- ✕Have currently received ixekizumab for more than 4 months or less than 2 months.
- ✕Have had any exposure to tirzepatide or other glucagon-like peptide-1 receptor agonist (GLP-1 RAs), for example, dulaglutide, liraglutide, or semaglutide.
- ✕Are currently enrolled in any other clinical study.
- ✕Other exclusions
- ✕Have a known hypersensitivity to tirzepatide or to any of its component.
- ✕Have a personal or family history of medullary thyroid cancer.
- ✕Have multiple endocrine neoplasia type 2.
- ✕Have type I diabetes mellitus.
- ✕Have a history of chronic or acute pancreatitis at any time before screening (Visit 1).
- ✕Have a history of proliferative diabetic retinopathy, diabetic maculopathy, or nonproliferative diabetic retinopathy that requires acute treatment.
- ✕Have a history of ketoacidosis or hyperosmolar state/coma.
- ✕Have a history of severe hypoglycemia and hypoglycemia unawareness within the 6 months before screening.
- ✕Have a history of severe gastrointestinal complications, including gastroparesis, gastroesophageal reflux disease, dyspepsia, chronic nausea/constipation/vomiting.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.